BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor™ System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53615-bd-veritor-system-influenza-test-receives-510k-clearance-fda-clia-waiver
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer that involve genes already targeted for drug development.
http://adultadhdtreatmentblog.com/adult-ritalin-is-this-effective-for-adult-adhd/ Occasionally trying to find an perfect grownup ADHD treatments and adult ritalin is really a seemingly endless array of medical medical doctors visits, medication modifications, and dosage adjustments. I understand your aggravation and share your discomfort. Nevertheless, existence will go on, so we must pick ourselves up and get back concerning the bus in make an effort to find that 1 grownup ADHD treatments that will assist us overcome those problematic grownup ADHD symptoms that may happen to be dogging us for years, for example inattention, impulsive behavior, and restlessness. Whilst this list won’t provide you with a brand new prescription drug alternative, it just might help you to improve your outcomes and minimize people pesky side effects. There
Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition.
The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
Upsher-Smith Laboratories, Inc. today announced the nationwide launch of Provella™, a unique probiotic dietary supplement specifically designed for women to promote digestive, feminine, and immune health.* Provella™ helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella™ tablets contain a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, and Bifidobacterium bifidum.
Provella™ is available without a prescription behind the pharmacy counter at retail pharmacies nationwide and online at www.drugstore.com. Consumers can also ask any local pharmacist to order Provella™ using List Number 0245-1060-30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56871-upsher-smith-provella-probiotic-supports-digestive-feminine-immune-health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Whether from a supermarket, farm stand, or your own garden, fresh fruits and vegetables are highlights of summertime. The U.S. Food and Drug Administration reminds you that foodborne bacteria multiply faster in warm weather – and what’s more, safe handling of produce and fresh-squeezed juice is especially important because these foods are often consumed raw.
Keep foods safe this summer by practicing the Four Steps to Food Safety: clean hands and surfaces often; separate raw meats from other foods; cook to the right temperatures; and chill foods promptly. And with delicious, nutritious produce and fresh-squeezed juices, follow these additional tips to prevent food poisoning.
To view Multimedia News Release, go to https://www.multivu.com/mnr/50947-usfda-foodborne-bacteria-safe-handling-food-produce-fresh-juice
Estado de gracia, la serie dramática de ficción sobre el narcotráfico que aborda por primera vez el polémico tema de la legalización de las drogas en México, se estrena el lunes 4 de junio, en exclusiva a través de Cinelatino, el canal líder de películas en español en Estados Unidos. La serie que cuenta con altos estándares de producción no se ha visto en ningún otro país en el mundo.
Esta producción mexicana es un thriller de suspenso político que presenta un retrato realista sobre el fenómeno del narcotráfico en México, que arroja luz sobre la red de dinero, el poder y la corrupción que alimenta el negocio ilícito de las drogas.
Para más, va a http://www.multivu.com/mnr/56310-cinelatino-estado-de-gracia-mexico-drug-trade-legalization?lang=es
Sir Richard Branson, Archbishop Desmond Tutu, John Paul DeJoria, Founder of Paul Mitchell, bestselling authors and speakers Jack Canfield, Gregg Braden and Barbara Marx Hubbard; three-time Nobel nominated Dr. Scilla Elworthy; philanthropist James Caan; former financial fund manager Alison Pothier; drug-addicted armed robber-turned-social entrepreneur Brett Moran; 12-year-old natural food advocate Birke Baehr and Harry Massey, Health technology inventor. What do all these visionaries have in common?
To view Multimedia News Release, go to http://www.multivu.com/mnr/58713-branson-choice-point-new-movie
In preparation for July 4th and the summer months when instances of food poisoning increase, the Ad Council and the U.S. Department of Agriculture’s Food Safety and Inspection Service, in partnership with the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), are continuing their national Food Safe Families public service campaign, the first multimedia effort designed to raise awareness of the risks of foodborne illness (or food poisoning) in the home.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56338-ad-council-usda-hhs-food-safe-families-public-service-campaign
Phoenix Children’s Hospital announced the creation of the Ronald A. Matricaria Institute of Molecular Medicine today, with the goal to unlock genetic codes and develop drug therapies in real time to improve the outcome for thousands of young patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59399-phoenix-children-s-hospital-visionary-institute-of-molecular-medicine
Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta’s revolutionary new Agility™* MLC promises a new level of precision and delivery speed in radiation therapy treatments for cancer patients. Elekta recently received 510(k) clearance (K121328) from the U.S. Food and Drug Administration (FDA) for Agility, enabling U.S. medical centers to provide these clinical benefits to their patients with cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55638-elekta-agility-radiation-therapy-radiotherapy-cancer-sbrt
